We are live on
!
Find out more
PMSA
Patrick M. Sweeney & Associates Portfolio holdings
AUM
$156M
1-Year Est. Return
19.16%
This Fund
S&P 500
This Quarter
Est. Return
+3.97%
1 Year Est. Return
+19.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$160M
AUM Growth
+$5.19M
(+3.4%)
Cap. Flow
+$874K
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
38.06%
Holding
164
New
5
Increased
70
Reduced
63
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$603K |
| 2 |
NVIDIA
NVDA
|
+$530K |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$489K |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$413K |
| 5 |
General Motors
GM
|
+$225K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$517K |
| 2 |
DuPont de Nemours
DD
|
+$261K |
| 3 |
Dow Inc
DOW
|
+$234K |
| 4 |
Haleon
HLN
|
+$219K |
| 5 |
Target
TGT
|
+$205K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.97% |
| 2 | Financials | 19.38% |
| 3 | Technology | 15.19% |
| 4 | Industrials | 14.18% |
| 5 | Communication Services | 5.19% |
Similar funds
BCM
IWA
CFG
BCM
AIS
BWM
MCA
TI
Patrick M. Sweeney & Associates's Q4 2025 Portfolio in Review
As of Q4 2025, Patrick M. Sweeney & Associates held 164 positions worth $160M, up 3.4% from $155M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Patrick M. Sweeney & Associates's Q4 2025 filing shows 5 new, 70 increased, 63 reduced and 5 closed positions. Its largest new stake was Vanguard FTSE Europe ETF: 5,082 shares worth $425K. The largest sale was Pfizer, an estimated $517K.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
- Patrick M. Sweeney & Associates's largest Q4 2025 buy was Vanguard FTSE Europe ETF: 5,082 shares worth $425K.
- Patrick M. Sweeney & Associates added most to Vanguard S&P 500 ETF in Q4 2025, an estimated $603K increase.
- Patrick M. Sweeney & Associates's biggest Q4 2025 reduction was Pfizer, cutting an estimated $517K.
- Patrick M. Sweeney & Associates fully exited DuPont de Nemours in Q4 2025, selling an estimated $261K.
- Patrick M. Sweeney & Associates's ten largest holdings make up 38% of its $160M portfolio in Q4 2025.
- Patrick M. Sweeney & Associates opened 5 new positions and closed 5 in Q4 2025.
- Patrick M. Sweeney & Associates's portfolio value rose 3.4% quarter-over-quarter to $160M.
Based on Patrick M. Sweeney & Associates's 13F filing for Q4 2025, filed 4 Feb 2026.